MSFT
51
-4
PBI
68
3
AKAM
47
5
NOC
56
2
ADBE
49
3
WHR
72
2
HRB
65
6
M
31
-5
NTRS
59
2
STI
12
-5
INTC
48
5
AA
57
-6
WAT
61
-3
LUV
48
3
AMP
76
3
KMX
61
3
DNB
88
2
CSX
68
3
EMC
56
-9
MS
81
2
MSFT
51
-4
PBI
68
3
AKAM
47
5
NOC
56
2
ADBE
49
3
WHR
72
2
HRB
65
6
M
31
-5
NTRS
59
2
STI
12
-5
INTC
48
5
AA
57
-6
WAT
61
-3
LUV
48
3
AMP
76
3
KMX
61
3
DNB
88
2
CSX
68
3
EMC
56
-9
MS
81
2
Financhill
Back

Schmid Group NV 10K Form

Sell
25

SHMD
Schmid Group NV

Last Price:
2.64
Seasonality Move:
1.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SHMD News And Ratings

See the #1 stock for the next 7 days that we like better than SHMD

SHMD Financial Statistics

Sales & Book Value

Annual Sales: $97.7M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-0.83
Price / Book: 0

Profitability

EPS (TTM): 1.20260
Net Income (TTM): $40.18M
Gross Margin: $28.58M
Return on Equity: 0%
Return on Assets: 0%

Schmid Group NV Earnings Forecast

Key Schmid Group NV Financial Ratios

  • The Gross Profit Margin over the past 3 years for SHMD is 29.25%.
  • The Selling, General & Administrative Expenses for SHMD have been equal to 27.83% of Gross Profit Margin.
  • The Research & Development expenses have been 5.70% of Revenue.
  • The Interest Expense is 27.37% of Operating Income.
  • The Net Earning history of SHMD is 40.85% of Total Revenues.
  • Per Share Earnings over the last 3 years have been positive in 2 years.

Schmid Group NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electronic Equipment, Instruments & Components
Sector: Information Technology
Current Symbol: SHMD
Website: schmid-group.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SHMD Technical Analysis vs Fundamental Analysis

Sell
25
Schmid Group NV (SHMD) is a Sell

Is Schmid Group NV a Buy or a Sell?

  • Schmid Group NV stock is rated a Sell
    The current Schmid Group NV [SHMD] share price is $2.48. The Score for SHMD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.